U.S. clinical trial begins for Endosense's ablation catheter

02/5/2013 | AuntMinnie.com (free registration)

The University of Virginia Medical Center in Charlottesville has become the first in the U.S. to use Endosense's TactiCath Quartz ablation catheter as part of an investigational device exemption clinical trial of the device. Trial results will be used to back the company's FDA premarket approval application for the system, which it aims to file during the fourth quarter of this year.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA